Trial site
Ann & Robert H. Lurie Children's Hospital
- 10running trials
- 5closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers6 trials
- Acute lymphoblastic leukaemia2 trials
- Acute myeloid leukaemia2 trials
- Asthma1 trial
- Congenital heart disease1 trial
- Cushing's syndrome1 trial
- Heart failure1 trial
- Hypertrophic cardiomyopathy1 trial
- Liver cirrhosis1 trial
- Mitochondrial disease1 trial
- Sarcoma1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 25 trials
- Phase 1/22 trials
- Phase 11 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Completed5 trials
- Recruiting5 trials
- Enrolling by invitation3 trials
- Active, not recruiting2 trials
- Suspended1 trial
- Lead sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago3 trials
- Arbor Research Collaborative for Health2 trials
- Berlin Heart, Inc1 trial
- BioMarin Pharmaceutical1 trial
- COUR Pharmaceutical Development Company, Inc.1 trial
- and 8 more
Running trials
Recruiting
Active, not recruiting
Recruiting
Safety and Feasibility of Intraoperative Visualization With Cytalux in Children
Enrolling by invitation
Recombinant Zoster Vaccine in Young Adult Solid Organ Transplant Recipients
Recruiting
Enrolling by invitation
EXCOR Active Driving System for the EXCOR Pediatric VAD IDE Study
Recruiting
Enrolling by invitation
Recruiting
Recruiting
Ovarian Tissue Cryopreservation in Post Pubertal (OTC-Post Pubertal)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers3 recruiting
- Acute myeloid leukaemia1 recruiting
- Congenital heart disease1 recruiting
- Cushing's syndrome1 recruiting
- Heart failure1 recruiting
- Sarcoma1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Testing "SupporT for ADHD and Related Treatment" (START) for Families of Children With ADHD
Completed
PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study
Completed
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Completed
Completed
A Multicenter, Multinational, Observational Morquio A Registry Study (MARS)
Site data: ClinicalTrials.govUpdated 17 Nov 2026